TY - JOUR
T1 - Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK
T2 - implications for skeletal muscle function
AU - Close, G.L.
AU - Russell, J.
AU - Cobley, J.N.
AU - Owens, D.J.
AU - Wilson, G.
AU - Gregson, W.
AU - Fraser, W.D.
AU - Morton, J.P.
PY - 2013
Y1 - 2013
N2 - The current study implemented a two-part design to (1) assess the vitamin D concentration of a large cohort of non-vitamin D supplemented UK-based athletes and 30 age-matched healthy non-athletes and (2) to examine the effects of 5000 IU · day−1 vitamin D3 supplementation for 8-weeks on musculoskeletal performance in a placebo controlled trial. Vitamin D concentration was determined as severely deficient if serum 25(OH)D < 12.5 nmol · l−1, deficient 12.5–30 nmol · l−1 and inadequate 30–50 nmol · l−1. We demonstrate that 62% of the athletes (38/61) and 73% of the controls (22/30) exhibited serum total 25(OH)D < 50 nmol · l−1. Additionally, vitamin D supplementation increased serum total 25(OH)D from baseline (mean ± SD = 29 ± 25 to 103 ± 25 nmol · l−1, P = 0.0028), whereas the placebo showed no significant change (53 ± 29 to 74 ± 24 nmol · l−1, P = 0.12). There was a significant increase in 10 m sprint times (P = 0.008) and vertical-jump (P = 0.008) in the vitamin D group whereas the placebo showed no change (P = 0.587 and P = 0.204 respectively). The current data supports previous findings that athletes living at Northerly latitudes (UK = 53° N) exhibit inadequate vitamin D concentrations (<50 nmol · l−1). Additionally the data suggests that inadequate vitamin D concentration is detrimental to musculoskeletal performance in athletes. Future studies using larger athletic groups are now warranted.
AB - The current study implemented a two-part design to (1) assess the vitamin D concentration of a large cohort of non-vitamin D supplemented UK-based athletes and 30 age-matched healthy non-athletes and (2) to examine the effects of 5000 IU · day−1 vitamin D3 supplementation for 8-weeks on musculoskeletal performance in a placebo controlled trial. Vitamin D concentration was determined as severely deficient if serum 25(OH)D < 12.5 nmol · l−1, deficient 12.5–30 nmol · l−1 and inadequate 30–50 nmol · l−1. We demonstrate that 62% of the athletes (38/61) and 73% of the controls (22/30) exhibited serum total 25(OH)D < 50 nmol · l−1. Additionally, vitamin D supplementation increased serum total 25(OH)D from baseline (mean ± SD = 29 ± 25 to 103 ± 25 nmol · l−1, P = 0.0028), whereas the placebo showed no significant change (53 ± 29 to 74 ± 24 nmol · l−1, P = 0.12). There was a significant increase in 10 m sprint times (P = 0.008) and vertical-jump (P = 0.008) in the vitamin D group whereas the placebo showed no change (P = 0.587 and P = 0.204 respectively). The current data supports previous findings that athletes living at Northerly latitudes (UK = 53° N) exhibit inadequate vitamin D concentrations (<50 nmol · l−1). Additionally the data suggests that inadequate vitamin D concentration is detrimental to musculoskeletal performance in athletes. Future studies using larger athletic groups are now warranted.
KW - 25(OH)D
KW - Vitamin D
KW - Supplementation
KW - deficiency
UR - https://www.scopus.com/pages/publications/84874797621
U2 - 10.1080/02640414.2012.733822
DO - 10.1080/02640414.2012.733822
M3 - Article
SN - 0264-0414
VL - 31
SP - 344
EP - 353
JO - Journal of Sports Sciences
JF - Journal of Sports Sciences
IS - 4
ER -